Perbedaan BFI Finance Indonesia Tbk dan Tempo Scan Pacific Tbk.: BFI Finance Indonesia Tbk diperdagangkan di Rp785 (kapitalisasi pasar 12,03 T, volume 24 jam 12,2 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.500 (kapitalisasi pasar 11,36 T, volume 24 jam 200 rb). Perbedaan utamanya: BFI Finance Indonesia Tbk dan Tempo Scan Pacific Tbk. berukuran mirip dari sisi kapitalisasi pasar, dan BFI Finance Indonesia Tbk lebih aktif diperdagangkan (12,2 jt vs 200 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BFIN | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 12,03 T | 11,36 T |
Volume | 12,2 jt | 200 rb |
Lot | 122 rb | 2 rb |
Perputaran | 9,55 M | 500,06 jt |
Harga Rata-rata | 782,93 | 2.500,28 |
Nilai Transaksi | 9,55 M | 500,06 jt |
Harga Ekuilibrium Indikatif | 785 | 2.500 |
Volume Ekuilibrium Indikatif | 5,52 rb | 100 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT BFI Finance Indonesia Tbk (the Company) formerly PT. Bunas Finance Indonesia Tbk (the Company) was established as PT Manufacturers Hanover Leasing Indonesia on April 7, 1982 based on Notarial deed No. 57 of Kartini Muljadi, S.H., Notary in Jakarta. Presently, the Company is engaged in leasing, consumer financing and factoring of accounts receivable. And changed to BFI Finance Indonesia on 2001
Selengkapnya di halaman BFIN →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →